The biology of incipient, pre-invasive or intraepithelial neoplasia

Cancer Biomarkers

Volumn 9, Issue 1-6, 2011, Pages 21-39

  Grizzle, William E ^a   Srivastava, Sudhir ^b   Manne, Upender ^a  

^a University of Alabama at Birmingham   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

actinic keratosis; adenomatous polyps; angiogenesis; carcinogens; cervical intraepithelial neoplasia; ductal carcinoma in situ; dysplasia; inflammation; Intraepithelial neoplasia; lobular carcinoma in situ; LOCDIR; pancreatic intraepithelial neoplasia; pre invasive neoplasia; prostatic intraepithelial neoplasia; radiation; repair; viral infections

Indexed keywords

BENZENE; CARCINOGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR ANTIGEN; TUMOR MARKER;

ACTINIC KERATOSIS; ANGIOGENESIS; ARTICLE; BOWEN DISEASE; BREAST ADENOCARCINOMA; CANCER GRADING; CANCER INVASION; COLORECTAL CARCINOMA; DERMAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; INTRAEPITHELIAL NEOPLASIA; INVASIVE CARCINOMA; IONIZING RADIATION; LUNG ADENOCARCINOMA; LUNG DYSPLASIA; MOLECULARLY TARGETED THERAPY; NONHUMAN; ORAL INTRAEPITHELIAL NEOPLASIA; PANCREAS ADENOCARCINOMA; PANCREAS INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC PROLIFERATIVE INFLAMMATORY ATROPHY; PULMONARY INTRAEPITHELIAL NEOPLASIA; SMALL BOWEL ADENOCARCINOMA; STOMACH ADENOCARCINOMA; TOBACCO; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; UTERINE CERVIX CARCINOMA IN SITU;

ANIMALS; CARCINOMA IN SITU; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNOLOGIC SURVEILLANCE; METAGENOME; MICE; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS;

EID: 82955180347     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0172     Document Type: Article

References (74)

1. W. E. Grizzle, R. B. Myers and U. Manne, The use of biomarker expression to characterize neoplastic processes, Biotech Histochem 2(21997), 96-104.
2. R. B. Myers and W. E. Grizzle, Biomarker Expression in Prostatic Intraepithelial Neoplasia, Eur Urol 30(21996), 153-166. PMID: 8875196.
3. W. E. Grizzle, R. B. Myers, M. A. Arnold and S. Srivastava, Evaluation of biomarkers in breast and prostate cancer, J Cell Biochem 19 (1994), 259-266.
4. W. D. Dupont and D. L. Page, Risk factors for breast cancer in women with proliferative breast disease, N Engl J Med 312 (1985), 146-151.
5. J. E. McNeal and D. G. Bostwick, Intraductal dysplasia; a premalignant lesion of the prostate, Hum Pathol 17 (1986), 64-71.
6. D. G. Bostwick, M. B. Amin and P. Dundore, Architectural patterns of high-grade prostatic intraepithelial neoplasia, Hum Pathol 42 (1993), 298-310.
7. D. C. Bostwick andM. K. Brawer, Prostate intra-epithelial neoplasia and early invasion in prostate cancer, Cancer 59 (1987), 788-794.
8. N. V. Adsay, Pathological classification of cystic neoplasms of the pancreas in pancreatic cancer In: Pancreatic Cancer, D. D. Von Hoff, D. B. Evans and R. H. Hruban, eds, 2005, pp. 716- 735.
9. A. M. De Marzo, V. L. Marchi, J. I. Epstein and W. G. Nelson, Proliferative inflammatory atrophy of the prostate: Implications or prostatic carcinogenesis, Am J Pathol 155 (1999), 1985-1199.
10. M. J. Gandour and W. E. Grizzle, A Small Adrenocortical Carcinomawith Aggressive Behavior. An evaluation of criteria for malignancy, Arch Pathol Lab Med 110(111986), l076-l079.
11. J. E. McNeal, A. Villers, E. A. Redwine, F. S. Freiha and T. A. Stamey, Microcarcinoma in the prostate: its association with duct-acinar dysplasia, Human Pathol 22 (1991), 644-652.
12. S. J. Winawer, A. G. Zauber, M. N. Ho, M. J. O'Brien, L. S. Gottlieb, S. S. Sternberg, J. D. Waye, M. Shapiro, J. H. Bond, J. F. Panish, F. Ackroyd, M. Shike, R. C. Kurtz, L. Hornsby- Lewis, H. Gerdes and E. T. Stewart, The National Polyp Study Workgroup, Prevention of colorectal cancer by colonoscopic polypectomy, New Engl J Med 329(271993), 1977-1981.
13. D. K. Rex, Colonoscopy, A review of its yield for cancers and adenomas by idication, Am J Gastroenterol 90(31995), 353-365.
14. S. Beenken, M. Sellers, P. Huang, G. Peters, H. Krontiras, P. Dixon, C. Stockard, C. Listinsky and W. E. Grizzle, Transforming growth factor α (TGFα) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid, Head Neck 21(61999), 566-573.
15. L. G. Koss, Epidermoid carcinoma of the uterus, cervix and related precancerous lesions in: LG Koss's Diagnostic cytology and its istopathologic bases. 3rd edition, (pp. 285-375) Philadelphia: J. B. Lippincott Company, 1979.
16. E. R. Fearon and B. A. Vogelstein, A genetic model for colorectal carcinogenesis, Cell 61 (1990), 579-567.
17. Y. Ionov, M. A. Peinado, S. Malkhosyan, S. Shibata and M. Perucho, Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis, Nature 363 (1993), 5658-5561.
18. N. Honnavara, S. M. Ananthaswamy, P. C. Loughlin, R. L. Evans, S. E. Ullrich and M. L. Kripke, Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens, Nature Medicine 3(51997), 510-526.
19. G. Ling, A. Persson, B. Berne, M. Uhlén, J. Lundeberg and F. Ponten, Persistent p53 mutations in single cells from normal human skin, Am J Pathol 159 (2001), 1247-1253.
20. A. S. Jonason, S. Kunala, G. J. Price, R. J. Restifo, H. M. Spinelli, J. A. Persing, D. J. Leffell, R. E. Tarone and D. E. Brash, Frequent clones of p53-mutated keratinocytes in normal human skin, PNAS 93(241996), 14025-14029.
21. C. Ginestier, M. H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C. G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M. S. Wicha and G. Dontu, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomes, Cell Stem Cell 1 (2007), 555-567.
22. M. Kaharala andM. S. Wicha, Implications of the cancer stemcell hypothesis for breast cancer prevention and therapy, J Clin Oncol 26 (2008), 2813-2820.
23. E. Charafe-Jauffret, F. Monville, C. Ginestier, G. Dontu, D. Birnbaum and M. S. Wicha, Cancer stem cells in breast: Current opinion and future challenges, Pathobiology 75 (2008), 75-84.
24. E. Charafe-Jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, P. Finetti, M-H. Hur, M. E. Diebel, F. Monville, J. Dutcher, M. Brown, P. Viens, L. Xerri, F. Bertucci, G. Stassi, G. Dontu, D. Birnbaum and M. S. Wicha, Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature, Cancer Res 69(42009), 1302-1313.
25. G. Pershagen, G. Akerblom, O. Axelson, B. Clavensjo, L. Damber, G. Desai, A. Enflo, F. Lagarde, H. Mellander, M. Svartengren and G. A. Swedjemark, Residential radon exposure and lung cancer in Sweden, NEJM 330 (1994), 159-164.
26. A. Ouhtit, H. Nakazawa, B. K. Armstrong, A. ricker, E. Tan, H. Yamasaki and D. R. English, UV-radiation-specific p53mutation frequently in normal skin as a predictor of risk of basal cell carcinoma, J Natl Cancer Inst 90 (1998), 523-531.
27. D. E. Brash, J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin and J. Pontén, A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma, Proc Natl Acad Sci USA 88 (1991), 10124-10128.
28. C. Campbell, A. G. Quinn, Y-S. Ro, B. Angus and J. L. Rees, P53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin, J Invest Dermatol 100 (1993), 746-748.
29. M. Murata, M. Tagawa, S. Watanabe, H. Kimura, T. Takeshita and K. Morimoto, Genotype difference of aldehydedehydrogenase 2 gene in alcohol drinkers influences the incidence of Japanese colorectal cancer patients, Japanese Journal of Cancer Research 90 (1999), 711-719.
30. M. Pereira, G. M. Goldberg, J. Bar-Ziv and G. Danovitch, Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas, Oncology Reports 6 (1999), 597-599.
31. B. Shannon, S. Gnanasampanthan, J. Beilby and B. Iacopetta, A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability, Gut 50 (2002), 520-524.
32. E. L. Abel and J. DiGiovanni, Environmental carcinogenesis In: The Molecular Basis of Cancer, (3rd ed. ), B. Craig, M. D. Thompson, J. W. Gray and J. Mendelsohn, 2008, pp. 91-113.
33. K. G. Daniel, D. Chen, S. Oriu, Q. C. Cui, F. R. Miller and Q. P. Dou, Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells, Breast Cancer Research 7 (2005), (R897-R908). Doi:16. 1186/bcr1322.
34. H. Feng, M. Shuda, Y. Chang and P. S. Moore, Clonal integration of a polyomavirus in human Merkel cell carcinoma, Science 319 (2008), 1096-1100.
35. T. A. Brentnall, D. A. Crispin, M. P. Bronner, S. P. Cherian, M. Hueffed, P. S. Rabinovitch, C. E. Rubin, R. C. Haggitt and C. R. Boland, Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis, Cancer Res 56 (1996), 1237-1240.
36. T. A. Brentnall, R. Chen, J. G. Lee, M. B. Kimmey, M. P. Bronner, R. C. Haggitt, K. V. Kowdley, L. M. Hecker and Dr. Byrd, Microsatellite instability and k-ras mutations associated with pancreatic adenocarcinoma and pancreatitis, Cancer Res 55 (1995), 4264-4267.
37. R. F. Willenbucher, D. E. Aust, C. G. Chang, S. J. Zelman, L. D. Ferrell, D. H. II. Moore and F. M. Waldman, Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia, Am J Pathol 154 (1999), 1825-1830.
38. L. A. Loeb, A mutator phenotype in cancer, Cancer Res 61 (2001), 3230-3239.
39. K. R. Loeb and L. A. Loeb, Genetic instability and the mutator phenotype. Studies in ulcerative colitis, American Journal of Pathology 154 (1999), 1621-1626.
40. C. D. Heinen, A. E. Noffsinger, J. Belli, J. Straughen, J. Fischer, J. Groden and C. M. Fenoglio-Preiser, Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation, Genes Chromosomes and Cancer 19 (1997), 170-175.
41. S. Lee, J. Jeong, T. Majewski, S. E. Scherer, M-S. Kim, T. Tuziak, K. S. Tang, K. Baggerly, H. B. Grossman, J-H. Zhou, L. Shen, J. Bondaruk, S. S. Ahmed, S. Samanta, P. Spiess, X. Wu, S. Filipek, D. McConkey, M. Bar-Eli, J-P. Issa, W. F. Benedict and B. Czerniak, Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia, PNAS 104(342007), 13732-13737
42. M. -S. Kim, J. Jeong, T. Majewski, A. Kram, D. -S. Yoon, R. -D. Zhang, J. -Z. Li, K. Ptaszynski, T. C. Kuang, J-H. Zhou, U. G. Sathyanarayana, T. Tuziak, D. A. Johnston, H. B. Grossman, A. F. Gazdar, S. E. Scherer, W. F. Benedict and B. Czerniak, Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia, Laboratory Investigation 86 (2006), 175-190.
43. L. Valle, T. Serena-Acedo, S. Liyanarachi, H. Hampel, I. Comeras, Z. Li, Q. Zeng, H-T. Zhang, M. J. Pennison, M. Sadim, B. Pasche, S. M. Tanner and A. de la Chapelle, Germline allelespecific expression of TGFBR1 confers an increased risk of colorectal cancer, Science 321 (2008), 1361-1365.
44. Q. Zeng, S. Phukan, Y. Xu, M. Sadim, D. S. Rosman, M. Pennison, J. Liao, G-Y. Yang, C-C. Huang, L. Valle, A. Di Cristofano, A. de la Chappelle and A. Pasche, Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development, Cancer Res 69(22009), 678-686.
45. V. G. Kaklamani, K. B. Wisinski, M. Sadim, C. Gulden, A. Do, K. Offit, J. A. Baron, H. Ahsan, C. Mantzoros and B. Pasche, Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk, JAMA 300(132008), 1523-1131.
46. H. G. Zhang and W. E. Grizzle, Aging, immunity, and tumor susceptibility, Immunol Allergy Clin N Am 23 (2003), 83-102.
47. W. E. Grizzle, O. J. Semmes,W. Bigbee, L. Zhu,G. Malik, D. K. Oelschlager, B. Manne and U. Manne, The need for the review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis, Cancer Informatics 1(12005), 86-97.
48. Remenyiké, N. M. Wikonkál, W. Zhang, V. Pailwal and D. E. Brash, Antigen-specific immunity does not mediate acute regression of UVB-induced p53-mutant clones, Oncogene 22 (2003), 6369-6376.
49. D. I. Gabrilovich and S. Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol 9 (2009), 162-174.
50. C. Liu, S. Yu, J. Kappes, J. Wang,W. E. Grizzle, K. R. Zinn and H-G. Zhang, Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host, Blood 109 (2007), 4336-4342.
51. C. Liu, S. Yu, K. Zinn, J. Wang, L. Zhang, Y. Jia, J. C. Kappes, S. Barnes, R. P. Kimberly, W. E. Grizzle and H. G. Zhang, Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function, J Immunol 176 (2006), 1375-1385.
52. G-J. Wang, Y. Liu, A. Qin, S. V. Shah, Z-B. Den, X. Xiang, Z. Chang, C. Liu, J. Wang, L. Zhang, W. E. Grizzle and H-G. Zhang, Thymus exosomes-like particles induce regulatory T cells, J Immunol 181 (2008), 5242-5248.
53. A. Clayton, J. Court, H. Navabi, M. Adams, M. D. Mason, J. A. Hobot, G. R. Newman and B. Jasani, Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry, J Immunol Methods 247 (2001), 163-174.
54. L. Blanc, C. Barres, P. Bette-Bobillo and M. Vida, Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2, Blood 110 (2007), 3407-3416.
55. C. Théry, L. Zitvogel and S. Amigorena, Exosomes: composition, biogenesis and function, Nat Rvw Immunol 2 (2002), 569-579.
56. X. Xiang, A. Poliakov, C. Liu, Y. Liu, Z-B. Deng, J. Wang, Z. Cheng, S. V. Shah, G-J. Wang, L. Zhang, W. E. Grizzle, J. Mobley and H. -G. Zhang, Induction of myeloid-derived suppressor cells by tumor exosomes, In J Cancer 124 (2009), 2621-2623.
57. S. Yu, C. Liu, K. Su, J. Wang, Y. Liu, L. Zhang, C. Li, Y. Cong, R. Kimberly, W. E. Grizzle, C. Falkson and H-G. Zhang, Tumor exosomes inhibit differentiation of bonemarrow dendritic cells, J Immunol 178 (2007), 6867-6875.
58. W. D. Dupont and D. L. Page, Risk factors for breast cancer in women with proliferative breast disease, N Engl J Med 312 (1985), 146-151.
59. D. L. Page, W. D. Dupont, L. W. Rogers and M. Landenberger, Intraductal carcinoma of the breast: follow-up after biopsy only, Cancer 49 (1982), 751-758.
60. D. L. Page, W. D. Dupont, L. W. Rogers, R. A. Jensen and P. A. Schuyler, Continued local recurrence of carcinoma 15- 25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy, Cancer 76 (1995), 1197-1200.
61. J. I. Epstein, Pathology in prostate cancer, principles and practice. Ed. Kantoff PW, Carroll PR, and D'Amico AV, Philadelphia: Lippincott William and Wilkins (2002), 232-253.
62. C. Shanmugam, V. R. Katkoori, N. C. Jhala, W. E. Grizzle, G. P. Siegal and U. Manne, p53 Nuclear Accumulation and Bcl-2 Expression in Contiguous Adenomatous Components of Colorectal Adenocarcinomas Predict Aggressive Tumor Behavior, J Histochem Cytochem 56(32008), 305-312. PMCID: PMC2324183.
63. W. E. Grizzle, D. Shibata, U. Manne, R. B. Myers and A. R. Frost, Molecular and Histopathologic Changes in the Development of Colorectal Neoplasia. In: Molecular Pathology of Early Cancer, S. Srivastava, D. E. Henson and A. Gazdar, eds, IOS Press, Amsterdam, Netherlands, 1999, Chapter 10, pp. 135-170.
64. S. Beenken, Jr. R. Hockett, W. Grizzle, H. L. Weiss, A. Pickens, M. erloff, W. F. Malone and K. I. Bland, Transforming growth factor α (TGF-α): A surrogate endpoint biomarker? J Am Coll Surg 195(22002), 149-158.
65. L. Norton and J. Massagué, Is cancer a disease of selfspreading? Nature Medicine 12(82006), 875-878.
66. L. Norton, Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications, Breast Dis 29 (2008), 27-36 PubMed PMID: 19029622.
67. E. P. Sandgren, Mouse models of exocrine pancreatic cancer. In: Pancreatic Cancer, D. D. Hoff, D. B. Evans and R. H. Hruban, eds, Jones and Bartlett Publishers, Sudbury, Massachusetts, Chapter 6, 2005, pp. 87-100.
68. A. J. Aguirre, N. Bardessy, M. Sinha, L. opez, D. A. Tuveson, J. Horner, M. S. Redston and R. A. DePinho, Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma, Genes and Development 17 (2003), 3112-3126.
69. R. H. Jr. Bell, V. A. Memoli and D. S. Longneker, Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene, Carcinogenesis 11 (1990), 1393-1398.
70. D. S. Klimstra, J. Rosai and C. S. Heffess, Mixed acinarendocrine carcinomas of the pancreas, Am J Surg Pathol 18 (1994), 765-778.
71. K. Kojima, S. M. Vickers, V. Adsay, N. C. Jhala, H-G. Kim, T. R. Schoeb, W. E. Grizzle and C. A. Klug, Inactivation of Smad4 accelerates KrasG12D-mediated pancreatic neoplasia, Cancer Res 67(172007), 8121-8130.
72. M. M. Winslow and T. Jacks, Genetic mousemodels of cancer. In: The Molecular Basis of Cancer, J. Mendelsohn, P. M. Howley, M. A. Israel, J. W. Gray and C. B. Thompson, eds, 3rd edition. Saunders Elsevier 2008 Chapter 9, pp. 129-138.
73. K. Cole, M. Tabernero and K. S. Anderson, Biologic characteristics of premalignant breast disease, Cancer Biomark 9 (2011), 177-192.
74. S. Srivastava and W. E. Grizzle, Biomarkers and the genetics of early neoplastic lesions, Cancer Biomark 9 (2011), 41-64.